researchdrivelogo.jpg
Global Mobile Tomography Market Anticipated to Garner $1,371.1 Million, Growing with 8.2% CAGR in the 2022–2031 Timeframe [240-Pages] | Depicted by Research Dive
21 mars 2023 09h05 HE | Research Dive
New York, USA, March 21, 2023 (GLOBE NEWSWIRE) -- Research Dive has published a new report on the global mobile tomography market. According to the report, the global market is projected to surpass...
Magnetic Resonance Imaging (MRI) Market_11zon.jpg
Global Magnetic Resonance Imaging (MRI) Market to Generate USD 12.19 Billion by 2030, Outlines a New Report by Next Move Strategy Consulting
27 févr. 2023 09h00 HE | Next Move Strategy Consulting
New York, Feb. 27, 2023 (GLOBE NEWSWIRE) -- According to the report published by Next Move Strategy Consulting, the Magnetic Resonance Imaging (MRI) Market generated USD 7.55 billion in 2022, and is...
xeltis_logo_cmyk_rectangular-e1567683187818.jpg
Xeltis raises €32 million to drive clinical development of world’s most advanced restorative cardiovascular devices
21 févr. 2023 01h00 HE | Xeltis
Xeltis raises €32 million to drive clinical development of world’s most advanced restorative cardiovascular devices New investors DaVita Venture Group and Invest-NL join syndicate of international...
Vascular Closure Devices Market Size Worth USD 1.9 Billion by 2030 at 7.30% CAGR - Report by Market Research Future (MRFR)
06 oct. 2022 11h30 HE | Market Research Future
New York, USA, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Vascular Closure Devices Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Vascular Closure Device...
TeleflexLogo.jpg
Teleflex Announces First Patient Enrollment in MANTA Ultra Study
22 juin 2022 06h30 HE | Teleflex Incorporated
WAYNE, Pa., June 22, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the first patient enrollment in a clinical study...
TeleflexLogo.jpg
Teleflex Announces Health Canada Approval of MANTA® Vascular Closure Device
18 mai 2022 06h30 HE | Teleflex Incorporated
WAYNE, Pa., May 18, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced that it received Health Canada approval for the...
Access Vascular Logo Hi Res.png
Access Vascular Inc. and Eloquest Healthcare Partner to Improve Vascular Access Outcomes
27 oct. 2021 08h00 HE | Access Vascular
BEDFORD, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications, today announced it has formed a...
Access Vascular Logo Hi Res.png
New Access Vascular Clinical Studies Find Catheters Composed of Advanced Biomaterials Significantly Reduce Complication Rates
20 sept. 2021 08h00 HE | Access Vascular
BEDFORD, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications through its advanced biomaterial...
RapidPulse Launches With $15 Million Series A Financing for Ischemic Stroke Therapy
23 juin 2021 09h00 HE | RapidPulse, Inc
MIAMI, June 23, 2021 (GLOBE NEWSWIRE) -- RapidPulse, Inc., a privately-held medical device company developing a novel aspiration system to treat ischemic stroke, today announced the closing of a $15...
BioAegis Therapeutics LOGO 2.5 x 5 150 pixel.jpg
Study Identifies New Role of BioAegis’ ‘Inflammation Regulator’ Gelsolin Relevant for a Range of Inflammatory Diseases
08 avr. 2021 18h58 HE | BioAegis Therapeutics
Gelsolin mitigates vascular damage by preventing release of IL-1β microparticles after trauma of high pressure and decompression.  Gelsolin is non-immunosuppressive unlike current treatments to quell...